N-[(4R)-4-(3,4-dimethoxyphenyl)-4-[1,3-dioxo-4-[4-[(1R)-1-phenylethyl]piperazin-1-yl]isoindol-2-yl]butyl]oxolane-3-carboxamide;N-[(4R)-4-(3,4-dimethoxyphenyl)-4-[1,3-dioxo-4-[4-(pyridin-3-ylmethyl)piperazin-1-yl]isoindol-2-yl]butyl]thiophene-2-sulfonamide;N-[(4R)-4-(3,4-dimethoxyphenyl)-4-[1,3-dioxo-4-[4-(thiophen-3-ylmethyl)piperazin-1-yl]isoindol-2-yl]butyl]thiophene-2-sulfonamide

C104H117N13O18S5 — CID 157360477

IUPACN-[(4R)-4-(3,4-dimethoxyphenyl)-4-[1,3-dioxo-4-[4-[(1R)-1-phenylethyl]piperazin-1-yl]isoindol-2-yl]butyl]oxolane-3-carboxamide;N-[(4R)-4-(3,4-dimethoxyphenyl)-4-[1,3-dioxo-4-[4-(pyridin-3-ylmethyl)piperazin-1-yl]isoindol-2-yl]butyl]thiophene-2-sulfonamide;N-[(4R)-4-(3,4-dimethoxyphenyl)-4-[1,3-dioxo-4-[4-(thiophen-3-ylmethyl)piperazin-1-yl]isoindol-2-yl]butyl]thiophene-2-sulfonamide
SMILESCOc1ccc([C@@H](CCCNC(=O)C2CCOC2)N2C(=O)c3cccc(N4CCN([C@H](C)c5ccccc5)CC4)c3C2=O)cc1OC.COc1ccc([C@@H](CCCNS(=O)(=O)c2cccs2)N2C(=O)c3cccc(N4CCN(Cc5cccnc5)CC4)c3C2=O)cc1OC.COc1ccc([C@@H](CCCNS(=O)(=O)c2cccs2)N2C(=O)c3cccc(N4CCN(Cc5ccsc5)CC4)c3C2=O)cc1OC
InChIInChI=1S/C37H44N4O6.C34H37N5O6S2.C33H36N4O6S3/c1-25(26-9-5-4-6-10-26)39-18-20-40(21-19-39)31-12-7-11-29-34(31)37(44)41(36(29)43)30(27-14-15-32(45-2)33(23-27)46-3)13-8-17-38-35(42)28-16-22-47-24-28;1-44-29-13-12-25(21-30(29)45-2)27(10-5-15-36-47(42,43)31-11-6-20-46-31)39-33(40)26-8-3-9-28(32(26)34(39)41)38-18-16-37(17-19-38)23-24-7-4-14-35-22-24;1-42-28-11-10-24(20-29(28)43-2)26(8-4-13-34-46(40,41)30-9-5-18-45-30)37-32(38)25-6-3-7-27(31(25)33(37)39)36-16-14-35(15-17-36)21-23-12-19-44-22-23/h4-7,9-12,14-15,23,25,28,30H,8,13,16-22,24H2,1-3H3,(H,38,42);3-4,6-9,11-14,20-22,27,36H,5,10,15-19,23H2,1-2H3;3,5-7,9-12,18-20,22,26,34H,4,8,13-17,21H2,1-2H3/t25-,28?,30-;27-;26-/m111/s1
InChIKeyBIORYMRMVHQWLU-IAAJMGALSA-N
MW1997.49 g/mol
LogP14.68
Rot. Bonds38

About N-[(4R)-4-(3,4-dimethoxyphenyl)-4-[1,3-dioxo-4-[4-[(1R)-1-phenylethyl]piperazin-1-yl]isoindol-2-yl]butyl]oxolane-3-carboxamide;N-[(4R)-4-(3,4-dimethoxyphenyl)-4-[1,3-dioxo-4-[4-(pyridin-3-ylmethyl)piperazin-1-yl]isoindol-2-yl]butyl]thiophene-2-sulfonamide;N-[(4R)-4-(3,4-dimethoxyphenyl)-4-[1,3-dioxo-4-[4-(thiophen-3-ylmethyl)piperazin-1-yl]isoindol-2-yl]butyl]thiophene-2-sulfonamide

N-[(4R)-4-(3,4-dimethoxyphenyl)-4-[1,3-dioxo-4-[4-[(1R)-1-phenylethyl]piperazin-1-yl]isoindol-2-yl]butyl]oxolane-3-carboxamide;N-[(4R)-4-(3,4-dimethoxyphenyl)-4-[1,3-dioxo-4-[4-(pyridin-3-ylmethyl)piperazin-1-yl]isoindol-2-yl]butyl]thiophene-2-sulfonamide;N-[(4R)-4-(3,4-dimethoxyphenyl)-4-[1,3-dioxo-4-[4-(thiophen-3-ylmethyl)piperazin-1-yl]isoindol-2-yl]butyl]thiophene-2-sulfonamide (PubChem CID 157360477) has the molecular formula C104H117N13O18S5 and a molecular weight of 1997.49 g/mol. Its IUPAC name is N-[(4R)-4-(3,4-dimethoxyphenyl)-4-[1,3-dioxo-4-[4-[(1R)-1-phenylethyl]piperazin-1-yl]isoindol-2-yl]butyl]oxolane-3-carboxamide;N-[(4R)-4-(3,4-dimethoxyphenyl)-4-[1,3-dioxo-4-[4-(pyridin-3-ylmethyl)piperazin-1-yl]isoindol-2-yl]butyl]thiophene-2-sulfonamide;N-[(4R)-4-(3,4-dimethoxyphenyl)-4-[1,3-dioxo-4-[4-(thiophen-3-ylmethyl)piperazin-1-yl]isoindol-2-yl]butyl]thiophene-2-sulfonamide.

Molecular Properties

Compound NameN-[(4R)-4-(3,4-dimethoxyphenyl)-4-[1,3-dioxo-4-[4-[(1R)-1-phenylethyl]piperazin-1-yl]isoindol-2-yl]butyl]oxolane-3-carboxamide;N-[(4R)-4-(3,4-dimethoxyphenyl)-4-[1,3-dioxo-4-[4-(pyridin-3-ylmethyl)piperazin-1-yl]isoindol-2-yl]butyl]thiophene-2-sulfonamide;N-[(4R)-4-(3,4-dimethoxyphenyl)-4-[1,3-dioxo-4-[4-(thiophen-3-ylmethyl)piperazin-1-yl]isoindol-2-yl]butyl]thiophene-2-sulfonamide
PubChem CID157360477
Molecular FormulaC104H117N13O18S5
Molecular Weight1997.49 g/mol
Exact Mass1995.72
IUPAC NameN-[(4R)-4-(3,4-dimethoxyphenyl)-4-[1,3-dioxo-4-[4-[(1R)-1-phenylethyl]piperazin-1-yl]isoindol-2-yl]butyl]oxolane-3-carboxamide;N-[(4R)-4-(3,4-dimethoxyphenyl)-4-[1,3-dioxo-4-[4-(pyridin-3-ylmethyl)piperazin-1-yl]isoindol-2-yl]butyl]thiophene-2-sulfonamide;N-[(4R)-4-(3,4-dimethoxyphenyl)-4-[1,3-dioxo-4-[4-(thiophen-3-ylmethyl)piperazin-1-yl]isoindol-2-yl]butyl]thiophene-2-sulfonamide
SMILESCOc1ccc([C@@H](CCCNC(=O)C2CCOC2)N2C(=O)c3cccc(N4CCN([C@H](C)c5ccccc5)CC4)c3C2=O)cc1OC.COc1ccc([C@@H](CCCNS(=O)(=O)c2cccs2)N2C(=O)c3cccc(N4CCN(Cc5cccnc5)CC4)c3C2=O)cc1OC.COc1ccc([C@@H](CCCNS(=O)(=O)c2cccs2)N2C(=O)c3cccc(N4CCN(Cc5ccsc5)CC4)c3C2=O)cc1OC
InChIInChI=1S/C37H44N4O6.C34H37N5O6S2.C33H36N4O6S3/c1-25(26-9-5-4-6-10-26)39-18-20-40(21-19-39)31-12-7-11-29-34(31)37(44)41(36(29)43)30(27-14-15-32(45-2)33(23-27)46-3)13-8-17-38-35(42)28-16-22-47-24-28;1-44-29-13-12-25(21-30(29)45-2)27(10-5-15-36-47(42,43)31-11-6-20-46-31)39-33(40)26-8-3-9-28(32(26)34(39)41)38-18-16-37(17-19-38)23-24-7-4-14-35-22-24;1-42-28-11-10-24(20-29(28)43-2)26(8-4-13-34-46(40,41)30-9-5-18-45-30)37-32(38)25-6-3-7-27(31(25)33(37)39)36-16-14-35(15-17-36)21-23-12-19-44-22-23/h4-7,9-12,14-15,23,25,28,30H,8,13,16-22,24H2,1-3H3,(H,38,42);3-4,6-9,11-14,20-22,27,36H,5,10,15-19,23H2,1-2H3;3,5-7,9-12,18-20,22,26,34H,4,8,13-17,21H2,1-2H3/t25-,28?,30-;27-;26-/m111/s1
InChIKeyBIORYMRMVHQWLU-IAAJMGALSA-N
XLogP14.68
TPSA330.52 Ų
H-Bond Donors3
H-Bond Acceptors28
Rotatable Bonds38
Heavy Atoms140
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001997.49
LogP ≤ 514.68
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 1028

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'phthalimide', 'substructure': 'N/A'}

Analyze N-[(4R)-4-(3,4-dimethoxyphenyl)-4-[1,3-dioxo-4-[4-[(1R)-1-phenylethyl]piperazin-1-yl]isoindol-2-yl]butyl]oxolane-3-carboxamide;N-[(4R)-4-(3,4-dimethoxyphenyl)-4-[1,3-dioxo-4-[4-(pyridin-3-ylmethyl)piperazin-1-yl]isoindol-2-yl]butyl]thiophene-2-sulfonamide;N-[(4R)-4-(3,4-dimethoxyphenyl)-4-[1,3-dioxo-4-[4-(thiophen-3-ylmethyl)piperazin-1-yl]isoindol-2-yl]butyl]thiophene-2-sulfonamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[(4R)-4-(3,4-dimethoxyphenyl)-4-[1,3-dioxo-4-[4-[(1R)-1-phenylethyl]piperazin-1-yl]isoindol-2-yl]butyl]oxolane-3-carboxamide;N-[(4R)-4-(3,4-dimethoxyphenyl)-4-[1,3-dioxo-4-[4-(pyridin-3-ylmethyl)piperazin-1-yl]isoindol-2-yl]butyl]thiophene-2-sulfonamide;N-[(4R)-4-(3,4-dimethoxyphenyl)-4-[1,3-dioxo-4-[4-(thiophen-3-ylmethyl)piperazin-1-yl]isoindol-2-yl]butyl]thiophene-2-sulfonamide?
The IUPAC name of N-[(4R)-4-(3,4-dimethoxyphenyl)-4-[1,3-dioxo-4-[4-[(1R)-1-phenylethyl]piperazin-1-yl]isoindol-2-yl]butyl]oxolane-3-carboxamide;N-[(4R)-4-(3,4-dimethoxyphenyl)-4-[1,3-dioxo-4-[4-(pyridin-3-ylmethyl)piperazin-1-yl]isoindol-2-yl]butyl]thiophene-2-sulfonamide;N-[(4R)-4-(3,4-dimethoxyphenyl)-4-[1,3-dioxo-4-[4-(thiophen-3-ylmethyl)piperazin-1-yl]isoindol-2-yl]butyl]thiophene-2-sulfonamide (CID 157360477) is N-[(4R)-4-(3,4-dimethoxyphenyl)-4-[1,3-dioxo-4-[4-[(1R)-1-phenylethyl]piperazin-1-yl]isoindol-2-yl]butyl]oxolane-3-carboxamide;N-[(4R)-4-(3,4-dimethoxyphenyl)-4-[1,3-dioxo-4-[4-(pyridin-3-ylmethyl)piperazin-1-yl]isoindol-2-yl]butyl]thiophene-2-sulfonamide;N-[(4R)-4-(3,4-dimethoxyphenyl)-4-[1,3-dioxo-4-[4-(thiophen-3-ylmethyl)piperazin-1-yl]isoindol-2-yl]butyl]thiophene-2-sulfonamide.
What is the SMILES notation for N-[(4R)-4-(3,4-dimethoxyphenyl)-4-[1,3-dioxo-4-[4-[(1R)-1-phenylethyl]piperazin-1-yl]isoindol-2-yl]butyl]oxolane-3-carboxamide;N-[(4R)-4-(3,4-dimethoxyphenyl)-4-[1,3-dioxo-4-[4-(pyridin-3-ylmethyl)piperazin-1-yl]isoindol-2-yl]butyl]thiophene-2-sulfonamide;N-[(4R)-4-(3,4-dimethoxyphenyl)-4-[1,3-dioxo-4-[4-(thiophen-3-ylmethyl)piperazin-1-yl]isoindol-2-yl]butyl]thiophene-2-sulfonamide?
The canonical SMILES for N-[(4R)-4-(3,4-dimethoxyphenyl)-4-[1,3-dioxo-4-[4-[(1R)-1-phenylethyl]piperazin-1-yl]isoindol-2-yl]butyl]oxolane-3-carboxamide;N-[(4R)-4-(3,4-dimethoxyphenyl)-4-[1,3-dioxo-4-[4-(pyridin-3-ylmethyl)piperazin-1-yl]isoindol-2-yl]butyl]thiophene-2-sulfonamide;N-[(4R)-4-(3,4-dimethoxyphenyl)-4-[1,3-dioxo-4-[4-(thiophen-3-ylmethyl)piperazin-1-yl]isoindol-2-yl]butyl]thiophene-2-sulfonamide is COc1ccc([C@@H](CCCNC(=O)C2CCOC2)N2C(=O)c3cccc(N4CCN([C@H](C)c5ccccc5)CC4)c3C2=O)cc1OC.COc1ccc([C@@H](CCCNS(=O)(=O)c2cccs2)N2C(=O)c3cccc(N4CCN(Cc5cccnc5)CC4)c3C2=O)cc1OC.COc1ccc([C@@H](CCCNS(=O)(=O)c2cccs2)N2C(=O)c3cccc(N4CCN(Cc5ccsc5)CC4)c3C2=O)cc1OC.
What is the InChIKey of N-[(4R)-4-(3,4-dimethoxyphenyl)-4-[1,3-dioxo-4-[4-[(1R)-1-phenylethyl]piperazin-1-yl]isoindol-2-yl]butyl]oxolane-3-carboxamide;N-[(4R)-4-(3,4-dimethoxyphenyl)-4-[1,3-dioxo-4-[4-(pyridin-3-ylmethyl)piperazin-1-yl]isoindol-2-yl]butyl]thiophene-2-sulfonamide;N-[(4R)-4-(3,4-dimethoxyphenyl)-4-[1,3-dioxo-4-[4-(thiophen-3-ylmethyl)piperazin-1-yl]isoindol-2-yl]butyl]thiophene-2-sulfonamide?
The InChIKey is BIORYMRMVHQWLU-IAAJMGALSA-N. The full InChI is InChI=1S/C37H44N4O6.C34H37N5O6S2.C33H36N4O6S3/c1-25(26-9-5-4-6-10-26)39-18-20-40(21-19-39)31-12-7-11-29-34(31)37(44)41(36(29)43)30(27-14-15-32(45-2)33(23-27)46-3)13-8-17-38-35(42)28-16-22-47-24-28;1-44-29-13-12-25(21-30(29)45-2)27(10-5-15-36-47(42,43)31-11-6-20-46-31)39-33(40)26-8-3-9-28(32(26)34(39)41)38-18-16-37(17-19-38)23-24-7-4-14-35-22-24;1-42-28-11-10-24(20-29(28)43-2)26(8-4-13-34-46(40,41)30-9-5-18-45-30)37-32(38)25-6-3-7-27(31(25)33(37)39)36-16-14-35(15-17-36)21-23-12-19-44-22-23/h4-7,9-12,14-15,23,25,28,30H,8,13,16-22,24H2,1-3H3,(H,38,42);3-4,6-9,11-14,20-22,27,36H,5,10,15-19,23H2,1-2H3;3,5-7,9-12,18-20,22,26,34H,4,8,13-17,21H2,1-2H3/t25-,28?,30-;27-;26-/m111/s1.
What are the key properties of N-[(4R)-4-(3,4-dimethoxyphenyl)-4-[1,3-dioxo-4-[4-[(1R)-1-phenylethyl]piperazin-1-yl]isoindol-2-yl]butyl]oxolane-3-carboxamide;N-[(4R)-4-(3,4-dimethoxyphenyl)-4-[1,3-dioxo-4-[4-(pyridin-3-ylmethyl)piperazin-1-yl]isoindol-2-yl]butyl]thiophene-2-sulfonamide;N-[(4R)-4-(3,4-dimethoxyphenyl)-4-[1,3-dioxo-4-[4-(thiophen-3-ylmethyl)piperazin-1-yl]isoindol-2-yl]butyl]thiophene-2-sulfonamide?
N-[(4R)-4-(3,4-dimethoxyphenyl)-4-[1,3-dioxo-4-[4-[(1R)-1-phenylethyl]piperazin-1-yl]isoindol-2-yl]butyl]oxolane-3-carboxamide;N-[(4R)-4-(3,4-dimethoxyphenyl)-4-[1,3-dioxo-4-[4-(pyridin-3-ylmethyl)piperazin-1-yl]isoindol-2-yl]butyl]thiophene-2-sulfonamide;N-[(4R)-4-(3,4-dimethoxyphenyl)-4-[1,3-dioxo-4-[4-(thiophen-3-ylmethyl)piperazin-1-yl]isoindol-2-yl]butyl]thiophene-2-sulfonamide has a molecular weight of 1997.49 g/mol, XLogP of 14.68, 38 rotatable bonds, 3 hydrogen bond donors, and 28 hydrogen bond acceptors.
Where does this data come from?
All data for N-[(4R)-4-(3,4-dimethoxyphenyl)-4-[1,3-dioxo-4-[4-[(1R)-1-phenylethyl]piperazin-1-yl]isoindol-2-yl]butyl]oxolane-3-carboxamide;N-[(4R)-4-(3,4-dimethoxyphenyl)-4-[1,3-dioxo-4-[4-(pyridin-3-ylmethyl)piperazin-1-yl]isoindol-2-yl]butyl]thiophene-2-sulfonamide;N-[(4R)-4-(3,4-dimethoxyphenyl)-4-[1,3-dioxo-4-[4-(thiophen-3-ylmethyl)piperazin-1-yl]isoindol-2-yl]butyl]thiophene-2-sulfonamide is sourced from PubChem (CID 157360477), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).